首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2076696篇
  免费   154619篇
  国内免费   3779篇
耳鼻咽喉   30934篇
儿科学   66053篇
妇产科学   60496篇
基础医学   301988篇
口腔科学   59649篇
临床医学   178408篇
内科学   399060篇
皮肤病学   43326篇
神经病学   166508篇
特种医学   83360篇
外国民族医学   546篇
外科学   323632篇
综合类   47849篇
现状与发展   3篇
一般理论   569篇
预防医学   154047篇
眼科学   49025篇
药学   157326篇
  1篇
中国医学   4012篇
肿瘤学   108302篇
  2018年   19830篇
  2016年   17628篇
  2015年   20401篇
  2014年   27695篇
  2013年   42086篇
  2012年   58077篇
  2011年   61079篇
  2010年   35950篇
  2009年   33466篇
  2008年   58883篇
  2007年   64049篇
  2006年   64406篇
  2005年   63734篇
  2004年   61454篇
  2003年   59758篇
  2002年   58228篇
  2001年   88365篇
  2000年   90472篇
  1999年   76994篇
  1998年   22621篇
  1997年   20397篇
  1996年   20294篇
  1995年   19134篇
  1994年   18209篇
  1993年   16889篇
  1992年   62543篇
  1991年   61574篇
  1990年   60580篇
  1989年   58781篇
  1988年   54772篇
  1987年   53862篇
  1986年   51404篇
  1985年   49363篇
  1984年   37493篇
  1983年   32413篇
  1982年   19847篇
  1981年   17894篇
  1979年   36658篇
  1978年   26086篇
  1977年   22254篇
  1976年   20844篇
  1975年   22872篇
  1974年   27537篇
  1973年   26595篇
  1972年   25271篇
  1971年   23473篇
  1970年   22070篇
  1969年   21315篇
  1968年   19807篇
  1967年   17740篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
33.
34.
35.
36.
37.
38.
39.
Pediatric trachyonychia is an acquired nail disease that can cause distress to families. It is a poorly understood disease, and long‐term follow‐up data are lacking. We present an institutional review of 11 children with isolated pediatric trachyonychia followed over time. Children with the diagnosis of pediatric trachyonychia were identified and invited to participate. Pictures were taken on follow‐up and a questionnaire was answered. Exclusion criteria include having another diagnosis at the initial visit that causes nail dystrophy. Eleven patients with the diagnosis of pediatric trachyonychia were available for follow‐up. The mean age of appearance was 2.7 years (range 2–7 yrs) and the average follow‐up was 66 months (range 10–126 mos). Nine patients were treated with potent topical corticosteroids, one used only petrolatum, and one took vitamin supplements. One patient was found to have an additional skin and hair diagnosis of alopecia areata on follow‐up. On follow‐up, 82% noted improvement of the nails, whereas 18% noted no change. A majority of cases of pediatric trachyonychia are isolated and improve with time, regardless of treatment.  相似文献   
40.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号